ENDOVALVE
Percutaneous valve-replacement systems to treat mitral regurgitation.
Launch date
Market cap
-
Enterprise valuation
CAD44—65m (Dealroom.co estimates Feb 2007.)
Princeton New Jersey (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$2.5m | Series A | ||
$8.0m | Series B | ||
N/A | Acquisition | ||
| Total Funding | CAD14.3m | ||